Grunenthal Logo

External Link

You are now leaving the Grünenthal (UK) website. You will be re-directed to an external website. Grünenthal UK Ltd. accepts no responsibility for the content of other websites.

Grünenthal Limited Office Building Maidenhead, UK

Grünenthal presence in the United Kingdom

Grünenthal Ltd., a subsidiary of Grünenthal GmbH, was established in 2004.

The company includes Regulatory, Medical Information, Sales, and Marketing divisions and Market Access and Medical Science Liaison teams. It currently markets medications to relieve or manage moderate to severe pain to GPs, hospital doctors, pharmacists, and nurses.

United Kingdom
 United Kingdom

Grünenthal Limited
TOR Building, St Cloud Way
SL6 8BN Maidenhead, Berkshire
United Kingdom

+44 0800 254 5540
generalenquiriesuk@grunenthal.com

THE GRÜNENTHAL WORLD - Global Company Background 

Grünenthal is a global company based in Aachen, Germany, with affiliates in 28 countries across Europe, Latin America, and the US. Our products benefit patients in around 100 countries worldwide. 

As a family-owned business, we have been delivering innovative medicines for over 75 years, focusing on pain treatments for the past five decades. We aim to strengthen our leadership in this field by creating cutting-edge, non-opioid therapies. 

We cover the full value chain from research to distribution and collaborate with top scientific organizations to enhance our impact. Our company's profitable growth has been driven by acquisitions of established brands that secure our financial stability and enable investments in research. 

Get a quick overview on our business in our digital company showcase:

Experience our virtual company showcase

Grünenthal at a glance – experience our virtual company showcase

Who are we? What are we doing? How are we doing it? Our digital company overview quickly answers big questions about Grünenthal.
Read about our key objectives and activities, as well as our recent business development highlights and financial performance. Get insights into our leadership team, strategy and financials, R&D & Pipeline, Product portfolio, Reliable Supply, Environmental & Societal Governance, and our Company culture and purpose.
Cover picture Grünenthal Report 2025/2026

Grünenthal Report 2025/26

Grünenthal is driven by a clear and ambitious vision: a World Free of Pain. In 2025, we made significant progress in advancing innovative medicines for patients living with pain worldwide. The Grünenthal Report is a key way we share updates on our collective projects, priorities, and progress. It provides an overview of our continued efforts to move closer to our vision.
Responsibility Report 2024 Grünenthal

Responsibility Report 2024

As a recognised leader in environmental, social, and governance (ESG) matters, we proactively pursue best-in-class corporate sustainability practices. This report reflects the accomplishments of our teams worldwide around our focus areas of Patient People and Planet. Discover how our shared commitment is shaping long-term value.
M-N/A-UK-07-25-0005 August 2025